Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease. [PDF]
Int J Mol Sci, 2022 Leo D +5 more
europepmc +1 more source
TAAR1 as an emerging target for the treatment of psychiatric disorders. [PDF]
Pharmacol TherLiu J, Wu R, Li JX.
europepmc +1 more source
Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies. [PDF]
Pharmaceuticals (Basel), 2020 Francesconi V +6 more
europepmc +1 more source
TAAR1 deficiency impairs mitochondrial dynamics and synaptic integrity in the medial prefrontal cortex and associated cognition in mice. [PDF]
Transl PsychiatryZhang XQ +7 more
europepmc +1 more source
Unlocking the secrets of trace amine-associated receptor 1 agonists: new horizon in neuropsychiatric treatment. [PDF]
Front PsychiatryShajan B +3 more
europepmc +1 more source
Trace Amines and Trace Amine-Associated Receptors: A New Frontier in Cell Signaling. [PDF]
Cell Mol Neurobiol, 2020 Freyberg Z, Saavedra JM.
europepmc +1 more source
TAARs as Novel Therapeutic Targets for the Treatment of Depression: A Narrative Review of the Interconnection with Monoamines and Adult Neurogenesis. [PDF]
BiomedicinesShemiakova TS +2 more
europepmc +1 more source
Dualistic Dynamics in Neuropsychiatry: From Monoaminergic Modulators to Multiscale Biomarker Maps. [PDF]
BiomedicinesTanaka M, Battaglia S.
europepmc +1 more source
Trace amine-associated receptor 1 agonism promotes wakefulness without impairment of cognition in Cynomolgus macaques. [PDF]
Neuropsychopharmacology, 2019 Goonawardena AV +6 more
europepmc +1 more source
Molecular basis of human trace amine-associated receptor 1 activation. [PDF]
Nat CommunZilberg G +4 more
europepmc +1 more source